Press Room

Blog

17Sep17

CRO Market Growth

The global CRO market value is expected to exceed $32 billion in 2017 and reach $45 billion by 2022, according to a report by Grand View Research, with growth attributed to greater R&D spend, M&A activity, as well as government contracts with CROs. The role of CROs in helping pharma and biopharma firms address today’s complex drug development challenges, has grown considerably these past few years.

Kymos at 5th Antibody Industrial Symposium 2017
28Jun17

Kymos in the 5th Antibody Symposium 2017 in Tours, France

KYMOS participates with a booth in the 5th Antibody Industrial Symposium 2017, that takes place on June 27 and 28 in Tours, France. This year the scope of the Symposium is the Antibody-Drug Conjugates. An important pannel of experts presented the last innovations in this field and the new products that will be hopefully marketed in the years to come.

KYMOS and the IFTH
17Jun17

Great Success of the "Phase I Clinical Trials in Spain"

KYMOS is a proud to have been the sponsor and coorganizer of the "Phase I Clinical Trials in Spain" Session. The event took place on June 14 in the Barcelona Sicence Park and had a great success with around 100 attendees. KYMOS' CEO, Joan Puig de Dou, welcomed and farewelled the participants. Other KYMOS team members participate during the event: Lluisa Garcia (COO) moderated a roundtable and Jaume Pascual (Scientific Director Small Molecules) and Carles Celma (Scientific Director Biologics) exhibited very interesting scientific presentations.

Kymos at Rimini
08Jun17

Kymos in the 57 Simposium AFI at Rimini, June 7-9, 2017

KYMOS participates in the yearly conference of the Italian Association of Industry Pharmacists (AFI) in Rimini. KYMOS and its Italian affiliate PHARMAPROGRESS take up the stand #8 showing up its analytical capabilities in small molecules and biologics.